Quarterly Activities Report and 4C Quarterly Cash Flow Report

Patrys PATDX3 antibody drug conjugate significantly increases survival in animal model

Patrys AGM – 5th Nov 2021

Patrys demonstrates potential for deoxmabs in antibody drug conjugates (ADCs)

Patrys FY21 Annual Report

QUARTERLY ACTIVITIES REPORT & 4C

PAT-DX1 Significantly Improves Survival in Animal Model of Pancreatic Cancer

New data shows PAT-DX3 able to cross the blood brain barrier

New Data | PAT-DX1